It All Starts

with

Acorn developed the world’s first stem cell platform designed to collect, preserve, and enhance the potential of hair follicle stem cells for regenerative treatments today and tomorrow.

We’re at the Beginning of an Anti-Aging Revolution

A hundred years ago, medicine focused on treating symptoms. Today, we’re shifting toward regenerative solutions that restore and heal at the cellular level.

Acorn is at the forefront of this movement—helping people preserve their youngest, most potent cells for use in groundbreaking treatments.

Early studies on stem cells & tissue regeneration

1930-1950

The discovery of human pluripotent stem cells

1998

Exosome therapy & regenerative aesthetics gain traction

2010

First-to-market personalized secretome product

Today

1930-1950

1998

2010

Today

"I see it as being an enormous benefit to my patients. A way that people can prepare not only for aesthetics, but medical uses as well. It's a beautiful way to insure your future."

Dr. Jean Carruthers

Carruthers Cosmetics

Unlocking the Full Potential of Your Cells

Today

Topical

Professional secretome products for topical aesthetic use

Medium Term

Injectable

Personalized injectables using expanded live cells for restorative applications

Long Term

Advanced Medical Treatments

Advanced therapies with reprogrammed patient cells for regenerative medicine

As of December 2024

The Future is Bright

0 +

Active cell and gene-based clinical trials worldwide

0 +

Phase III clinical trials on regenerative therapies currently underway

0 +

Cell therapies approved globally

Backed by a Team of Scientists

ACORN was founded in 2017 by Dr. Drew Taylor, who unlocked the incredible potential of hair follicle stem cells during his PhD research at the University of Toronto. Acorn team brings together leading scientists, physicians, and lab experts dedicated to advancing regenerative medicine through cutting-edge work in Natural Killer cells, cartilage repair, organoid formation, and next-generation cell therapies.